← Open Payments lookup

BAKSHANDER KAUR: Open Payments

NPI 1477041192 · STOCKTON, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$853 in 30 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $336 · 2025 $853

Food & beverage: $853
CompanyPaymentsAmount
ABBVIE INC.13$293
Axsome Therapeutics, Inc.4$178
Otsuka America Pharmaceutical, Inc.1$125
Takeda Pharmaceuticals U.S.A., Inc.3$62
Neurocrine BioSciences, Inc.2$53
Lundbeck LLC2$46
Janssen Pharmaceuticals, Inc1$25
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$20
E.R. Squibb & Sons, L.L.C.1$20
Tris Pharma Inc1$17

Products named: VRAYLAR, Auvelity, REXULTI, TRINTELLIX, INGREZZA, INVEGA SUSTENNA, CAPLYTA, COBENFY.

Industry payments across CA — which companies pay providers there.